Fritextsökning
Innehållstyper
-
Cytel Inc acquires the SDS Group
The multinational statistical software developer and contract research organization Cytel Inc, headquartered in Massachusetts, USA, acquires the Swedish consult...
-
Carl Borrebaeck – professor and serial entrepreneur with a taste for speed
Award-winning cancer researcher, the founder of many listed companies, and constantly in the academic and commercial spotlight for decades. However, Carl Borreb...
-
Hello Jenni Nordborg!
Life Science Sweden would like to know more about Jenni Nordborg and asks her about her new job, why she became a chemical engineer and who her role model is.
-
Marie Gårdmark: Potential step change – EU regulators get to play with data
A new pilot from EMA is starting in September to assess wether the analysis of 'raw data' by regulatory authorities improves the evaluation of marketing approva...
-
Neanderthal genes and Nobel Prize in a popular lecture at Bioscience
An inherited gene variant from our ”evolutionary cousins” – the extinct Neanderthals – may affect how our bodies break down certain drugs. “It’s only a matter o...
-
Startup-bolaget vill bli nästa Olink
Inte ens ett år gamla har Rarity Bioscience fått anslag från Swelife och Medtech4health. Nu hoppas vd:n Linus Bosaeus att deras teknik för detektion av mutation...
-
“An entire industry is about to be wiped out”
According to Jennie Ekbeck, CEO of Umeå Biotech Incubators, Sweden risks not having any small diagnostic companies left in five years.
-
Study: An objective diagnosis of constant tinnitus may be possible
A new method that measures brain activity during sound stimulation can make it possible to objectively diagnose and identify people who suffer from constant tin...
-
Göran Stiernstedt: “We are the world’s worst at continuity”
Failed investments in primary care, an unreasonable system with online doctors and a public failure at coordinating the healthcare IT system. Göran Stiernstedt ...
-
Norrländsk life science går för högtryck
-
Pharma Outsourcing igång på Stockholm Waterfront
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Krönika: Can regulators keep up with innovation?
New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometime...
-
Ökat resultat för Sobi
Specialistläkemedelsbolaget Sobis rörelseresultat ökade med 74 procent för helåret.
-
Column: Repurposing as a golden ticket to approval
"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark...
-
Pengaregn över hälsoprojekt
22 projekt inom läkemedel, medtech och e-hälsa delar på 20,5 miljoner i Vinnova-utlysning.
-
Getinge vill köpa tyskt hjärtbolag
Planerar att lägga bud värt 139 miljoner euro.
-
Drug development creates new challenges for regulators
-
Koffein biomarkör för parkinsons
Forskare vid Juntendo University rapporterar om att använda blodnivåer av koffein och dess nedbrytningsprodukter som biomarkörer för Parkinsons sjukdom.
-
Karo dubblar vinsten och lanserar nytt
Specialistläkemedelsbolaget Karo Pharma dubblar omsättning och vinst under första kvartalet. Tillväxten drevs i huvudsak av förvärv. Planerar lansering av ny pr...
-
New diagnostic test soon ready for the market
-
Efterlysning: Organdonatorer
När Socialstyrelsen presenterar sin statistik över organdonationer under året, står en sak klar. De tillgängliga organen räcker inte.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Tillväxt för Elos
Visar upp en ökad orderingång men väntar sig en avmattning.